Can a single radiation dose cure large liver tumors?

NCT ID NCT06178198

First seen Aug 20, 2026 · Last updated Aug 21, 2026 · Updated 1 time

Summary

This trial is testing a high-dose radiation treatment called Yttrium-90 radioembolization for people with large hepatocellular carcinoma (a type of liver cancer) that is larger than 8 cm. The treatment delivers tiny radioactive beads directly to the tumor's blood supply, aiming to destroy it. The goal is to see if this approach can cure the cancer or shrink it enough to allow surgery. The study involves about 30 adults with good liver function and no spread of cancer outside the liver.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Yttrium-90 resin microspheres delivered via radioembolization
What this could lead to
If successful, this could offer a non-surgical curative option for large liver tumors, or shrink them enough to enable surgery.
What could go wrong
This is an early-phase, small trial. The treatment may not fully eliminate the tumor, and there are risks like radiation damage to the lungs or liver.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Seoul National University Hospital

    RECRUITING

    Seoul, Seoul, 03080, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.